Author: Samuel Weinstein, MD, MBA

Sam Weinstein, MD, MBA, Chief Executive Officer, leads SpecialtyCare’s commitment to improving clinical outcomes in a way that controls costs for customers. He joined SpecialtyCare in 2015 as Chief Medical Officer and was promoted to President and CMO in 2016. Sam’s impressive results in these roles led to him being elevated to CEO in September 2017. Prior to SpecialtyCare, Sam served as a medical operations consultant helping to improve performance for a variety of healthcare companies. He is a long-time proponent of evidence-based healthcare, with a special interest in quality reviews, data management, and medical leadership. Sam holds active board certifications in cardiothoracic surgery, congenital cardiac surgery, and general surgery. At The Children’s Hospital at Montefiore, he served as director of pediatric cardiothoracic surgery and surgical director of cardiac transplantation and mechanical assistance. Sam has a BA in History from the University of Pennsylvania and an MBA from Fordham University. He earned his medical degree at The State University of New York at Stony Brook and received postdoctoral training at The Columbia Presbyterian Medical Center and The Children’s Hospital of Philadelphia.

Congratulations to Our Brown-Brukardt Perfusion Scholarship Recipients

Congratulations to Our Brown-Brukardt Perfusion Scholarship Recipients

When we decided to create the Brown-Brukardt Perfusion Scholarships program in honor of Jim Brown and Gary Brukardt—men who helped advance the practice of perfusion—we felt it was important to find and support students with the potential to drive improvement in healthcare like Jim and Gary did throughout their careers. Today, we are proud to announce that Cassandra Wuest and Kyle Zelesnick are the recipients of our 2017 perfusion education scholarships, and they are even more talented and impressive than we had hoped.

Creating Certainty in an Uncertain Environment

SpecailtyCare creates certainty

From a healthcare perspective, the only thing we can be certain of in 2017 is that there will be uncertainty. For healthcare administrators, there is uncertainty around how to manage changes in provisions of the Affordable Care Act, Bundled Payments for Care Improvement (BPCI), and the Medicare Access and CHIP Reauthorization Act (MACRA). Restructuring Medicare and Medicaid could have a significant impact on planning, implementation, and payments for providers. But, regardless of the new format, healthcare providers like SpecialtyCare will always have an obligation—both to their patients and their customers—to improve value by providing high-quality care while containing costs.